The Role of TDP-43 in Alzheimer's Disease

被引:66
作者
Chang, Xiao-Long [1 ]
Tan, Meng-Shan [2 ]
Tan, Lan [1 ,2 ]
Yu, Jin-Tai [2 ,3 ]
机构
[1] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Peoples R China
[3] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
基金
中国国家自然科学基金;
关键词
TDP-43; A beta; Tau; Alzheimer's disease; Pathogenesis; Therapy; AMYOTROPHIC-LATERAL-SCLEROSIS; TAR-DNA-BINDING; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; MOUSE MODEL; PROTEIN; 43; MITOCHONDRIAL DYSFUNCTION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE;
D O I
10.1007/s12035-015-9264-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The transactive response DNA binding protein (TDP-43) has long been characterized as a main hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U, also known as FTLD-TDP). Several studies have indicated TDP-43 deposits in Alzheimer's disease (AD) brains and have robust connection with AD clinical phenotype. FTLD-U, which was symptomatically connected with AD, may be predictable for the comprehension of the role TDP-43 in AD. TDP-43 may contribute to AD through both beta-amyloid (A beta)-dependent and A beta-independent pathways. In this article, we summarize the latest studies concerning the role of TDP-43 in AD and explore TDP-43 modulation as a potential therapeutic strategy for AD. However, to date, little of pieces of the research on TDP-43 have been performed to investigate the role in AD; more investigations need to be confirmed in the future.
引用
收藏
页码:3349 / 3359
页数:11
相关论文
共 91 条
  • [61] TAR-DNA binding protein-43 and alterations in the hippocampus
    Rauramaa, Tuomas
    Pikkarainen, Maria
    Englund, Elisabet
    Ince, Paul G.
    Jellinger, Kurt
    Paetau, Anders
    Alafuzoff, Irina
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (05) : 683 - 689
  • [62] TARDBP mutations in Parkinson's disease
    Rayaprolu, Sruti
    Fujioka, Shinsuke
    Traynor, Sharleen
    Soto-Ortolaza, Alexandra I.
    Petrucelli, Leonard
    Dickson, Dennis W.
    Rademakers, Rosa
    Boylan, Kevin B.
    Graff-Radford, Neill R.
    Uitti, Ryan J.
    Wszolek, Zbigniew K.
    Ross, Owen A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2013, 19 (03) : 312 - 315
  • [63] BETA-AMYLOID PROTEIN DEPOSITION IN THE BRAIN AFTER SEVERE HEAD-INJURY - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE
    ROBERTS, GW
    GENTLEMAN, SM
    LYNCH, A
    MURRAY, L
    LANDON, M
    GRAHAM, DI
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (04) : 419 - 425
  • [64] No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease
    Robinson, A. C.
    Thompson, J. C.
    Weedon, L.
    Rollinson, S.
    Pickering-Brown, S.
    Snowden, J. S.
    Davidson, Y. S.
    Mann, D. M. A.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (07) : 844 - 854
  • [65] Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease
    Rohn, Troy T.
    [J]. BRAIN RESEARCH, 2008, 1228 : 189 - 198
  • [66] Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)
    Romano, Maurizio
    Buratti, Emanuele
    Romano, Giulia
    Klima, Raffaella
    Belluz, Lisa Del Bel
    Stuani, Cristiana
    Baralle, Francisco
    Feiguin, Fabian
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (10) : 7121 - 7130
  • [67] Mitochondrial Ca2+ Overload Underlies Aβ Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs
    Sanz-Blasco, Sara
    Valero, Ruth A.
    Rodriguez-Crespo, Ignacio
    Villalobos, Carlos
    Nunez, Lucia
    [J]. PLOS ONE, 2008, 3 (07):
  • [68] Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis
    Sasaki, Shoichi
    Takeda, Takahiro
    Shibata, Noriyuki
    Kobayashi, Makio
    [J]. NEUROSCIENCE LETTERS, 2010, 478 (02) : 72 - 76
  • [69] Is synaptic loss a unique hallmark of Alzheimer's disease?
    Scheff, Stephen W.
    Neltner, Janna H.
    Nelson, Peter T.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) : 517 - 528
  • [70] Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease
    Sheng, Baiyang
    Gong, Kai
    Niu, Ying
    Liu, Lingling
    Yan, Yufang
    Lu, Guangyuan
    Zhang, Lihai
    Hu, Min
    Zhao, Nanming
    Zhang, Xiufang
    Tang, Peifu
    Gong, Yandao
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (10) : 1362 - 1375